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Case ReportsAt this point, full inflation of the balloon was performed
with good expansion and anchoring of the device. Further
development of shorter-delivery catheters will facilitate
this intervention.
CONCLUSIONS
This patient presented a special combination of surgical
challenging problems, and it is unlikely that this approach
will becomewidely used; however, if indicated, the approach
is feasible and reproducible, and provides reliable results.From the Department of Thoracic and Vascular Surgery and Heart-Lung Transplan-
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valve technique. J Card Surg. 2012;27:196-8.Endovascular closure of Potts shunt before double lung
transplantation for idiopathic pulmonary arterial hypertensionMarina Paradela, MD, Olaf Mercier, MD, PhD, Alban Baruteau, MD, and Elie Fadel, MD, PhD,
Le Plessis-Robinson, FrancePotts shunt has been performed in children with severe
idiopathic pulmonary arterial hypertension (iPAH) as
a palliative treatment of right ventricular failure.1 This
procedure consists of a direct side-to-side anastomosis be-
tween the left pulmonary artery and the descending aorta.
It creates a similar hemodynamic condition to Eisen-
menger’s syndrome with an immediate clinical improve-
ment, but the disease process is unaffected. Indeed, lung
or heart-lung transplantations remain the ultimate treat-
ment if the condition worsens.2,3 Before transplantation,
closure of the Potts anastomosis is required to allow the
surgical procedure. We report a case of iPAH treated by
Potts shunt that had been closed with an aortic
endovascular stent-graft before double lung transplanta-
tion (DLTx).CLINICAL SUMMARY
A 14-year-old girl with a history of iPAH was referred to
the Marie Lannelongue Hospital for DLTx. She was diag-
nosed at 6 years of age and initially treated with bosentan
and epoprostenol. Two years later, she presented witha dyspnea New York Heart Association (NYHA)/World
Health Organization (WHO) functional class IV. She was
treated using a Potts shunt through a left thoracotomy with-
out cardiopulmonary bypass (CPB). The patient recovered
NYHA/WHO functional class II and was weaned from
epoprostenol.
Six years later, an episode of massive hemoptysis
developed in the patient. A thoracic contrast-enhancedFIGURE 1. Thoracic computed tomography showing the patent Potts
shunt, ascending aorta, descending aorta, and left pulmonary artery.
AAo, Ascending aorta; LPA, left pulmonary artery; DAo, descending aorta.
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FIGURE 2. Aortic and pulmonary angiograms showing the patent Potts
shunt (A) and the result of endovascular Potts shunt closure: Contrast is
injected in the descending aorta (B) and in the left pulmonary artery (C).
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e6 The Journal of Thoracic and Cardiovascular Surgecomputed tomography revealed multiple microaneurys-
mal arteriovenous fistulas in the distal branches of both
pulmonary arteries, affecting mainly the right lung. A
flexible bronchoscopy localized the bleeding within the
right lower lobe. An elective pulmonary angiography con-
firmed the origin of bleeding from an aneurysmal arterio-
venous fistula of the right lower lobe, which had been
embolized. The next day, a further episode of hemoptysis
was controlled by topical adrenaline and terlipressin. The
patient was then listed for DLTx. Two months later, she
presented a recurrent episode of hemoptysis accompanied
by worsening of dyspnea despite increasing doses of
bosentan and sildenafil. She was then switched to high-
priority status for DLTx and referred to our intensive
care unit.
On admission, physical examination demonstrated a sig-
nificant arterial oxygen saturationgradient between the upper
and lower limbs (90% and 79%, respectively) with hemato-
crit values of 48.5%. Echocardiography showed severe
pulmonary arterial hypertension (systolic pulmonary artery
pressure ¼ 125 mm Hg). A thoracic computed tomography
scan confirmed the Potts shunt patency (Figure 1), the persis-
tence of microaneurysms in distal pulmonary arteries, and
alveolar condensation in the right lower lobe.
Closure of the Potts shunt was performed just before the
transplant procedure once the donor lungs were inspected
and approved. An endovascular stent graft (Medtronic En-
durant 26 3 100 mm; Medtronic Inc, Minneapolis, Minn)
was implanted into the descending aorta with the proximal
end of the graft distal to the origin of the left subclavian
artery, closing the anastomosis (Figure 2). This procedure
was performed through the femoral artery under local an-
esthesia. A standard DLTx was subsequently performed
through a clamshell incision using CPB. A left pulmonary
artery anastomosis was performed proximal to the previ-
ous Potts shunt insertion, and the aorta was sewn over
the stent-graft by a running suture. Cold ischemia time
was 165 minutes for the right lung and 240 minutes for
the left lung. The patient was weaned from the ventilator
48 hours after surgery without inotropic support. The
postoperative course was uneventful. The patient was dis-
charged from the hospital on postoperative day 13 in good
condition.DISCUSSION
This case illustrates a useful hybrid approach in the man-
agement of end-stage iPAH previously treated with a Potts
shunt. At Marie Lannelongue Hospital, the palliative Potts
shunt has been used with promising results as an alternative
to atrial septostomy, in pediatric patients with iPAH and
suprasystemic pulmonary artery pressures, in patients
with NYHA/WHO functional class IV, and in nonre-
sponders to medical pulmonary arterial hypertensionry c July 2013
Case Reportstherapy.1 However, Potts shunt does not replace DLTx,
which remains the ultimate treatment for end-stage iPAH.
Closure of the Potts shunt was mandatory before estab-
lishing CPB. Surgical techniques, such as division of the
anastomosis with a separate closure of the aorta and the
pulmonary artery, occlusion of the shunt with a mechanical
stapler, and transpulmonary patch closure, have been
associated with high morbidity and mortality.4,5 Thus,
we decided to use an aortic endovascular stent graft to
close anastomosis. In contrast to surgical correction,
endovascular closure was easily performed under local
anesthesia without increasing the length of cold ischemia
or CPB. It proved to be a fast, safe, and effective
minimally invasive procedure allowing DLTx in standard
conditions. However, the long-term outcomes ofFrom the Department of Cardiothoracic Surgery,a Heart and Vascular Institute, the
Department of Internal Medicine and Infectious Disease,b Medicine Institute,
and the Department of Anatomic Pathology,c Laboratory Medicine Institute,
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molecular sequencing in cardiac surgerySyed T. Hussain, MD,a Steven M. Gordon, MD,b Carmela D. Tan, MD,c and Nicholas G. Smedira, MD,a
Cleveland, OhioMycoplasma hominis is part of the human microbial flora
of the genitourinary and respiratory tracts, but it is also an
extremely rare cause of endocarditis. We report a case of
prosthetic valve endocarditis caused by M hominis in
which the correct diagnosis was made by molecular se-
quencing of explanted valve tissue in response to a high
index of suspicion of an infectious process arising from
intraoperative findings despite negative results of routine
cultures.CLINICAL SUMMARY
A 57-year-old man had undergone aortic valve replace-
ment with a 19-mm bioprosthetic valve, pericardial patch
aortic root enlargement, and decalcification of the ante-
rior mitral valve leaflet in October 2011 at an outside hos-
pital. He started having increasing shortness of breath,
fatigue, and intermittent chest pain 4 to 5 months aftersurgery. The cardiovascular evaluation performed at that
time was unremarkable. He then was seen about 1 year
after operation with a near-syncopal event. An echocar-
diogram showed that the aortic prosthetic valve had
a peak gradient of 104 mm Hg. His coronary angiogram
appeared normal. A computed tomographic scan was sug-
gestive of a subvalvular obstruction of unclear etiology.
At that time, his appetite had deteriorated, and he had
lost about 14 kg during the previous few months, but he
had no fever or chills. Routine blood cultures yielded
negative results.
On the basis of these findings, the patient underwent
a cardiac reoperation in November 2012. Intraoperatively,
no purulence was found, although there was some fibrinoid
material on the aortic prosthesis. One of the prosthetic cusps
had torn from the commissure, resulting in aortic regurgita-
tion. After removal of just a few aortic prosthesis sutures,
the entire prosthesis came off easily, highly suggestive of
infectious endocarditis (IE). There was also subvalvular
stenosis that was not removable by forceps; it had to be cut
outwitha scalpel andwas thusnotconsistentwithavegetation.
There was no evidence of an aortic root abscess. The aortic
root was replaced with a size 18 aortic allograft.
Because of a high index of suspicion of IE related to the
operative findings, the bioprosthetic valve specimen was
sent to both microbiology and surgical pathology laborato-
ries according to our protocol. Results of routine valve cul-
tures were negative. Histopathologic examination of theardiovascular Surgery c Volume 146, Number 1 e7
